×

What are you searching for?




Business

4 Min read

Pfizer CEO BOURLA SOLD 62% OF HIS STOCK IN THE COMPANY

Published On 11 Nov 2020 05:35 PM


SHARE THIS ARTICLE  


Highlights

• According to filings registered with the Securities and Exchange Commission, Pfizer CEO sold 132,508 shares in the company at an average price of $41.94 per share, or $5.6 million

• The sale of this stock was carried through a routine 10b5-1 and now Bourla continues to own 81,812 shares in Pfizer

• Prior to sale, Bourla had announced that “The first set of results from our Phase 3....


Tags : Pfizer, Albert Bourla, COVID-19 vaccine, stocks, BioNTech, ,
SHARE THIS ARTICLE  

Leave a comment 

comments (0)